Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Buying Low & Selling High for TBP Breakthrough

<< Previous

Bullboard Posts

Next >>

Comment by Hoover69on Jan 22, 2023 4:02pm

314 Views

Post# 35238725

RE:Buying Low & Selling High for TBP Breakthrough

Salvage, this is both hilarious and sad. You have been buying TBP all the way from $0.15 down to $0.03! Just like you have been doing with Tilray and the rest of your 100% focused marijuana portfolio. And always talking about the "shorts". Your losses are huge. The desperation is sad. Perhaps you should try a GIC.